CAPITAL GROUP INVESTMENT MANAGEMENT PTE. LTD.
Position in ASND — Ascendis Pharma A/S
CIK 1939970
Raffles Quay, U0
Position in ASND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$775,088
+$110,399 QoQ
Shares Held
2,906
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#202
of 307 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL GROUP INVESTMENT MANAGEMENT PTE. LTD. holds $27,686,563 across 7 Biotechnology names. ASND ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,388 | $10,624,061 | |
| 2 | RPRX |
Royalty Pharma plc
|
126,078 | $7,069,193 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
16,840 | $4,798,894 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,474 | $1,948,868 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,938 | $1,831,960 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
2,906 | $775,088 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
11,707 | $638,499 |
All Filings in ASND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $775,088 | 2,906 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $664,689 | 2,906 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $619,675 | 2,906 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $771,780 | 3,882 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $670,033 | 3,882 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $605,048 | 3,882 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $496,851 | 3,609 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||